Inclusion further solidifies Somatus’ position as leading the transformation of the kidney care sector

May 19, 2022

MCLEAN, Va — Somatus, the nation’s leading and largest value-based kidney care company, announced it has been named a Top 50 Disruptor by CNBC.

According to the CNBC website, the list “highlights private companies that grew through the ups and downs of the pandemic and are poised to meet increasing economic and consumer challenges.”

Somatus Co-Founder and CEO Dr. Ikenna Okezie said of the news, “This acknowledgment recognizes the value of shifting care from being reactive to providing early, targeted, in-home comprehensive care. Our whole-person care approach leverages technology, highly skilled physicians, and multidisciplinary care teams to deliver more healthy days to patients.”

Somatus is disrupting the kidney care industry by using AI and predictive capabilities that enable the Company to surface opportunities to reduce costs and deliver better care. These results are driven by providing reliable predictions for patient outcomes and by identifying and eliminating healthcare disparities. With Somatus’ predictive analytics tools and the talent behind it, the Company can deliver enhanced care and improved outcomes for patients sooner.

About Somatus
Somatus is the leading provider of outcomes-driven care for individuals and communities living with chronic conditions. We partner with health plans, health systems, and clinicians to provide integrated care for patients with, or at risk of developing, cardiovascular-kidney-metabolic (CKM) and other chronic conditions. The company’s personalized, whole-person approach leverages local multi-disciplinary care teams, predictive analytics, and intelligent technologies to delay disease progression, improve quality of life, and reduce total cost of care. Somatus serves patients and caregivers in all 50 states and DC. Learn more at www.somatus.com.

Media Contact
Derek Kung
EVP, Chief of Staff, Somatus Inc.
[email protected]